J
J.P. Donnelly
Researcher at Radboud University Nijmegen
Publications - 110
Citations - 10656
J.P. Donnelly is an academic researcher from Radboud University Nijmegen. The author has contributed to research in topics: Transplantation & Mucositis. The author has an hindex of 46, co-authored 110 publications receiving 9865 citations. Previous affiliations of J.P. Donnelly include Hammersmith Hospital & National Institutes of Health.
Papers
More filters
Journal ArticleDOI
Defining Opportunistic Invasive Fungal Infections in Immunocompromised Patients with Cancer and Hematopoietic Stem Cell Transplants: An International Consensus
Sibel Ascioglu,John H. Rex,B.E. de Pauw,John E. Bennett,J. Bille,F. Crokaert,David W. Denning,J.P. Donnelly,J. E. Edwards,Z. Erjavec,D. Fiere,O. Lortholary,Johan Maertens,Jacques F. Meis,Thomas F. Patterson,J. Ritter,D. Selleslag,Palak Shah,David A. Stevens,Thomas J. Walsh +19 more
TL;DR: A set of research-oriented definitions for the IFIs most often seen and studied in immunocompromised patients with cancer is proposed and three levels of probability are proposed: "proven," "probable," and "possible."
Journal ArticleDOI
ESCMID guideline for the diagnosis and management of Candida diseases 2012: non-neutropenic adult patients.
Oliver A. Cornely,Matteo Bassetti,Thierry Calandra,Jorge Garbino,Bart Jan Kullberg,O. Lortholary,O. Lortholary,Wouter Meersseman,Murat Akova,Maiken Cavling Arendrup,S. Arikan-Akdagli,Jacques Bille,Elio Castagnola,Manuel Cuenca-Estrella,J.P. Donnelly,Andreas H. Groll,Raoul Herbrecht,William W. Hope,Henrik Jeldtoft Jensen,Cornelia Lass-Flörl,George Petrikkos,Malcolm Richardson,Emmanuel Roilides,Paul E. Verweij,Claudio Viscoli,Andrew J. Ullmann +25 more
TL;DR: This part of the EFISG guidelines focuses on non-neutropenic adult patients, and liposomal amphotericin B and voriconazole are supported with moderate, and fluconazole with marginal strength for the targeted initial treatment of candidaemia.
Journal ArticleDOI
EUCAST definitive document EDef 7.1: method for the determination of broth dilution MICs of antifungal agents for fermentative yeasts.
J. L. Rodriguez-Tudela,Maiken Cavling Arendrup,Francesco Barchiesi,Jacques Bille,Erja Chryssanthou,Manuel Cuenca-Estrella,Eric Dannaoui,David W. Denning,J.P. Donnelly,Françoise Dromer,W. Fegeler,Cornelia Lass-Flörl,Caroline B. Moore,Malcolm Richardson,Per Sandven,Aristea Velegraki,Paul E. Verweij +16 more
TL;DR: A Reference Laboratory for Mycology and Parasitology, National Center for Microbiology, Instituto de Salud Carlos III, Majadahonda, Spain.
Journal ArticleDOI
ESCMID guideline for the diagnosis and management of Candida diseases 2012:diagnostic procedures
Manuel Cuenca-Estrella,Paul E. Verweij,Maiken Cavling Arendrup,S. Arikan-Akdagli,Jacques Bille,J.P. Donnelly,Henrik Jeldtoft Jensen,Cornelia Lass-Flörl,Malcolm Richardson,Murat Akova,Matteo Bassetti,Thierry Calandra,Elio Castagnola,Oliver A. Cornely,Jorge Garbino,Andreas H. Groll,Raoul Herbrecht,William W. Hope,B.J. Kullberg,O. Lortholary,O. Lortholary,Wouter Meersseman,George Petrikkos,Emmanuel Roilides,Claudio Viscoli,Andrew J. Ullmann +25 more
TL;DR: In this paper, a panel of experts of the European Fungal Infection Study Group (EFISG) undertook a data review and compiled guidelines for the clinical utility and accuracy of different diagnostic tests and procedures for detection of Candida infections.
Journal ArticleDOI
ESCMID* guideline for the diagnosis and management of Candida diseases 2012: adults with haematological malignancies and after haematopoietic stem cell transplantation (HCT)
Andrew J. Ullmann,Murat Akova,Raoul Herbrecht,Claudio Viscoli,Maiken Cavling Arendrup,Sevtap Arikan-Akdagli,Matteo Bassetti,Jacques Bille,Thierry Calandra,Elio Castagnola,Oliver A. Cornely,J.P. Donnelly,Jorge Garbino,Andreas H. Groll,William W. Hope,Henrik Jeldtoft Jensen,Bart Jan Kullberg,Cornelia Lass-Flörl,O. Lortholary,O. Lortholary,Wouter Meersseman,Georgios Petrikkos,Malcolm Richardson,Emmanuel Roilides,Paul E. Verweij,Manuel Cuenca-Estrella +25 more
TL;DR: This part of the ESCMID guidelines focuses on this patient population and reviews pertaining to prophylaxis, empirical/pre-emptive and targeted therapy of Candida diseases, although a warning for resistance is expressed.